Idexx Laboratories Stock Today
| IDXX Stock | USD 477.79 0.45 0.09% |
Performance0 of 100
| Odds Of DistressLess than 1
|
IDEXX Laboratories is trading at 477.79 as of the 18th of April 2024; that is -0.09 percent decrease since the beginning of the trading day. The stock's open price was 478.24. IDEXX Laboratories has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for IDEXX Laboratories are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of March 2024 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 21st of June 1991 | Category Healthcare | Classification Health Care |
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine. The company has 83.05 M outstanding shares of which 1.76 M shares are currently shorted by private and institutional investors with about 4.54 trading days to cover. More on IDEXX Laboratories
Moving against IDEXX Stock
| 0.57 | GCTK | GlucoTrack | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 7th of May 2024
IDEXX Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. IDEXX Laboratories' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding IDEXX Laboratories or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, IDEXX Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to IDEXX Laboratories' managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
| CEO President | Jonathan Mazelsky | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Healthcare (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP 500 Index, Nasdaq 100, NASDAQ 100 Pre, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Healthcare, Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Excise Tax Activities | Animal Testing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering IDEXX Laboratories report their recommendations after researching IDEXX Laboratories' financial statements, talking to executives and customers, or listening in on IDEXX Laboratories' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering IDEXX Laboratories. The IDEXX consensus assessment is calculated by taking the average forecast from all of the analysts covering IDEXX Laboratories. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to IDEXX Laboratories' liquidity, profitability, solvency, and operating efficiency, IDEXX Laboratories is performing exceptionally good at this time. It has a great probability to report excellent financial results in May. Financial strength of IDEXX Laboratories is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IDEXX Laboratories' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to IDEXX Laboratories' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand IDEXX Laboratories' financial leverage. It provides some insight into what part of IDEXX Laboratories' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IDEXX Laboratories (IDXX) is traded on NASDAQ Exchange in USA. It is located in One IDEXX Drive, Westbrook, ME, United States, 04092 and employs 11,000 people. IDEXX Laboratories is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 40.66 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate IDEXX Laboratories's market, we take the total number of its shares issued and multiply it by IDEXX Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. IDEXX Laboratories conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 83.05 M outstanding shares of which 1.76 M shares are currently shorted by private and institutional investors with about 4.54 trading days to cover.
IDEXX Laboratories currently holds about 114.36 M in cash with 906.51 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37.
Check IDEXX Laboratories Probability Of Bankruptcy
Ownership AllocationIDEXX Laboratories has a total of 83.05 Million outstanding shares. The majority of IDEXX Laboratories outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in IDEXX Laboratories to benefit from reduced commissions. Thereupon, third-party entities are subject to a different set of regulations than regular investors in IDEXX Laboratories. Please pay attention to any change in the institutional holdings of IDEXX Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check IDEXX Ownership Details
IDEXX Stock Price Odds Analysis
Based on a normal probability distribution, the odds of IDEXX Laboratories jumping above the current price in 90 days from now is close to 99%. The IDEXX Laboratories probability density function shows the probability of IDEXX Laboratories stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.1311. This usually indicates IDEXX Laboratories market returns are sensitive to returns on the market. As the market goes up or down, IDEXX Laboratories is expected to follow. Additionally, iDEXX Laboratories has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of IDEXX Laboratories to move above the current price in 90 days from now is close to 99 (This IDEXX Laboratories probability density function shows the probability of IDEXX Stock to fall within a particular range of prices over 90 days) .
IDEXX Stock Institutional Holders
Institutional Holdings refers to the ownership stake in IDEXX Laboratories that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of IDEXX Laboratories' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing IDEXX Laboratories' value.| Instituion | Recorded On | Shares | |
| Brown Advisory Holdings Inc | 2023-12-31 | 1.2 M | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.1 M | |
| Capital World Investors | 2023-12-31 | 1 M | |
| Norges Bank | 2023-12-31 | 922.8 K | |
| Northern Trust Corp | 2023-12-31 | 862.6 K | |
| Jpmorgan Chase & Co | 2023-12-31 | 860.5 K | |
| Fundsmith Investment Services Ltd. | 2023-12-31 | 818.6 K | |
| Legal & General Group Plc | 2023-12-31 | 787.2 K | |
| Principal Financial Group Inc | 2023-12-31 | 781.4 K | |
| Blackrock Inc | 2023-12-31 | 9.1 M | |
| Vanguard Group Inc | 2023-12-31 | 8.4 M |
IDEXX Laboratories Historical Income Statement
IDEXX Laboratories Income Statement is one of the three primary financial statements used for reporting IDEXX's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of IDEXX Laboratories revenue and expense. IDEXX Laboratories Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, IDEXX Laboratories' Income Before Tax is fairly stable compared to the past year. Net Income is likely to rise to about 887.3 M in 2024, despite the fact that Total Other Income Expense Net is likely to grow to (34.2 M). View More FundamentalsIDEXX Stock Against Markets
Picking the right benchmark for IDEXX Laboratories stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in IDEXX Laboratories stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for IDEXX Laboratories is critical whether you are bullish or bearish towards IDEXX Laboratories at a given time. Please also check how IDEXX Laboratories' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in IDEXX Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
| All Next | Launch Module |
IDEXX Laboratories Corporate Directors
IDEXX Laboratories corporate directors refer to members of an IDEXX Laboratories board of directors. The board of directors generally takes responsibility for the IDEXX Laboratories' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of IDEXX Laboratories' board members must vote for the resolution. The IDEXX Laboratories board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Sophie Vandebroek | Director | Profile | |
| William End | Lead Independent Director | Profile | |
| Rebecca Henderson | Independent Director | Profile | |
| Anne Szostak | Independent Director | Profile |
How to buy IDEXX Stock?
Before investing in IDEXX Laboratories, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in IDEXX Laboratories. To buy IDEXX Laboratories stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of IDEXX Laboratories. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase IDEXX Laboratories stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located IDEXX Laboratories stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased IDEXX Laboratories stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as IDEXX Laboratories, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.
Already Invested in IDEXX Laboratories?
The danger of trading IDEXX Laboratories is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of IDEXX Laboratories is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than IDEXX Laboratories. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile IDEXX Laboratories is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether IDEXX Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IDEXX Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Idexx Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Idexx Laboratories Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for IDEXX Stock analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is IDEXX Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.121 | Earnings Share 10.04 | Revenue Per Share 44.073 | Quarterly Revenue Growth 0.088 | Return On Assets 0.2283 |
The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.